Search

Displaying results 6891 - 6900 of 8468 in total

Drug
Copper histidinate
go.drugbank.com/drugs/DB32041
Approved
It was approved by the US FDA in January 2026 for the treatment of pediatric patients with Menkes disease.[L54993,L54998]
Drug
Emrusolmin
go.drugbank.com/drugs/DB13927
Investigational
Emrusolmin restores hippocampal synaptic and transcriptional plasticity as well as spatial memory in a mouse model for Alzheimer's disease, when given orally before or after the onset of pathology.
Drug
BIIB015
go.drugbank.com/drugs/DB06304
Investigational
It has been investigated for the treatment of subjects with relapsed or refractory solid tumours.
Drug
Omecamtiv Mecarbil
go.drugbank.com/drugs/DB11816
Investigational
Omecamtiv Mecarbil has been used in trials studying the treatment and basic science of Heart Failure, Echocardiogram, Pharmacokinetics, Chronic Heart Failure, and History of Chronic Heart Failure, among
Drug
Dipropyl-4-hydroxytryptamine
go.drugbank.com/drugs/DB13990
Experimental
Dipropyl-4-hydroxytryptamine was first synthesized by Alexander Shulgin. This agent and its properties haven't been fully elucidated.
Drug
Creatinolfosfate
go.drugbank.com/drugs/DB13071
Investigational
COP has been investigated for the treatment of Diabetic Retinopathy.
Drug
(5Z,7E,9)-decatrien-2-one
go.drugbank.com/drugs/DB15619
Investigational
Similar to [(5E,7E,9)-decatrien-2-one], it has a strong pineapple aroma.[A191116]
Drug
Ultevursen
go.drugbank.com/drugs/DB17835
Investigational
It was developed by ProQR Therapeutics and is being investigated for the treatment of retinitis pigmentosa.
Drug
Denbufylline
go.drugbank.com/drugs/DB19482
Experimental
Denbufylline has a monoisotopic molecular weight of 320.18 Da.
Drug
Indolidan
go.drugbank.com/drugs/DB19499
Experimental
Indolidan has a monoisotopic molecular weight of 257.12 Da.